SAB Biotherapeutics, Inc. (SABS)

SAB Biotherapeutics Revenue

SAB Biotherapeutics had revenue of $377.84K in the twelve months ending March 31, 2025, down -85.48% year-over-year. In the year 2024, SAB Biotherapeutics had annual revenue of $1.32M, down -40.94%.

• Revenue (ttm): $377.84K
• Revenue Growth: -85.48%
• P/S Ratio: 43.94
• Revenue / Employee: $5,997
• Employees: 63
• Market Cap: 18.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.32M	-916.58K	-40.94%
Dec 31, 2023	2.24M	-21.67M	-90.63%
Dec 31, 2022	23.90M	-36.97M	-60.73%
Dec 31, 2021	60.88M	5.64M	10.21%
Dec 31, 2020	55.24M	51.80M	1,504.91%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.